Detalhe da pesquisa
1.
Profiling novel pharmacology of receptor complexes using Receptor-HIT.
Biochem Soc Trans
; 49(4): 1555-1565, 2021 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34436548
2.
Investigation of Receptor Heteromers Using NanoBRET Ligand Binding.
Int J Mol Sci
; 22(3)2021 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33499147
3.
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
J Am Soc Nephrol
; 30(11): 2191-2207, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511361
4.
Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor.
Int J Mol Sci
; 22(1)2020 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33379211
5.
Application of BRET to monitor ligand binding to GPCRs.
Nat Methods
; 12(7): 661-663, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26030448
6.
GPCR heteromers: An overview of their classification, function and physiological relevance.
Front Endocrinol (Lausanne)
; 13: 931573, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111299
7.
Orexin Signaling: A Complex, Multifaceted Process.
Front Cell Neurosci
; 16: 812359, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35496914
8.
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor.
Front Endocrinol (Lausanne)
; 13: 848816, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721749
9.
Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners.
Biochem Pharmacol
; 188: 114521, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741329
10.
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
Nat Commun
; 12(1): 1920, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772001
11.
NanoBRET: The Bright Future of Proximity-Based Assays.
Front Bioeng Biotechnol
; 7: 56, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972335
12.
NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.
Cell Signal
; 54: 27-34, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30471466
13.
BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes.
Biochem Pharmacol
; 158: 232-242, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30347205
14.
Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.
Sci Rep
; 7(1): 3187, 2017 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600500
15.
Corrigendum to "BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes" [Biochem. Pharmacol. 158 (2108) 232-242].
Biochem Pharmacol
; 192: 114756, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509100
16.
Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling.
Methods Mol Biol
; 1335: 191-204, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260602
17.
Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease.
PLoS One
; 10(3): e0119803, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807547
18.
Receptor-Heteromer Investigation Technology and its application using BRET.
Front Endocrinol (Lausanne)
; 3: 101, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22936924